The 7 major heterozygous familial hypercholesterolemia markets reached a value of US$ 10.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 32.9 Billion by 2034, exhibiting a growth rate (CAGR) of 11.14% during 2024-2034. https://www.imarcgroup.com/heterozygous-familial-hypercholesterolemia-market